Related Experiment Video
Updated: Jun 10, 2025
05:46
Establishing a Diaphyseal Femur Fracture Model in Mice
Published on: December 9, 2022
1.9K
Fracture Non-Union in Osteoporotic Bones: Current Practice and Future Directions
Chijioke Orji1, Charles Ojo2, Daniel E Onobun3
1Department of Trauma and Orthopedics, Liverpool University Hospitals NHS Foundation Trust, Liverpool, GBR.
Cureus
|October 21, 2024
Summary
Fracture non-union in osteoporotic bones is a growing orthopedic challenge. Novel therapies like stem cells and 3D printing offer promising, personalized solutions beyond traditional treatments.
Area of Science:
- Orthopedics
- Biomaterials Science
- Regenerative Medicine
Background:
- Osteoporotic bone fractures present a significant challenge due to poor bone quality and impaired healing.
- Aging global populations increase the incidence of osteoporotic fractures, leading to higher rates of delayed healing and non-union.
- Pathophysiology involves compromised bone regeneration, reduced osteoblast activity, and poor vascularity in osteoporotic patients.
Purpose of the Study:
- To review the challenges and advancements in managing fracture non-union in osteoporotic bones.
- To explore novel therapeutic strategies and emerging technologies for treating osteoporotic non-unions.
- To discuss evolving diagnostic approaches and future directions in personalized medicine for these complex fractures.
Main Methods:
- Review of traditional management strategies including pharmacological and surgical interventions.
- Analysis of recent advances in regenerative medicine, growth factors, stem cells, gene therapy, and bioactive scaffolds.
- Examination of emerging technologies such as 3D printing and nanotechnology in orthopedic applications.
- Evaluation of updated diagnostic methods including radiological assessments and biomarkers.
Main Results:
- Traditional treatments often show limited success due to the compromised nature of osteoporotic bone.
- Novel therapies offer targeted, biologically driven solutions with potential for improved outcomes.
- Advanced diagnostics aid in better risk identification for non-union.
- Emerging technologies enable customized treatment strategies.
Conclusions:
- Fracture non-union in osteoporotic bones requires integrated approaches combining traditional and innovative therapies.
- Personalized medicine and further clinical validation are crucial for optimizing outcomes.
- Emerging strategies represent a significant shift towards more effective management of these complex orthopedic cases.
More Related Videos
Related Concept Videos
01:27Fractures: Bone Repair
3.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.0K
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K